Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents
Author:
Funder
National Cancer Institute
AbbVie
Bristol-Myers Squibb
Merck Sharp & Dohme
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference20 articles.
1. B.A.R.C.O.S. (Brazilian Argentine Hepatitis C Collaborative Observational Study): effectiveness and clinical outcomes of HCV treatment with daclatasvir and sofosbuvir with or without ribavirin;Ridruejo;J Viral Hepat,2019
2. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis;Cheung;J Hepatol,2016
3. Overcoming barriers to hepatitis C elimination;Mendizabal;Frontline Gastroenterol,2019
4. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study;Carrat;Lancet,2019
5. Effect of paritaprevir/ritonavir/ombitasvir/dasabuvir and ledipasvir/sofosbuvir regimens on survival compared with untreated hepatitis C virus–infected persons: results from ERCHIVES;Butt;Clin Infect Dis,2017
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognosis Following Sustained Virologic Response in Korean Chronic Hepatitis C Patients Treated with Sofosbuvir-Based Treatment: Data from a Multicenter Prospective Observational Study up to 7 Years;Medicina;2024-07-14
2. The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes;Scientific Reports;2024-03-07
3. Five-year follow-up of sustained virological response with hepatitis C infection after direct-acting antiviral therapy: A single-center retrospective study;Medicine;2024-02-16
4. Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis;BMC Gastroenterology;2024-01-30
5. Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?;Clinics;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3